DUXAP9 and renal cell carcinoma: To explore whether IGF2BP2 affected the stability of DUXAP9 in RCC, we knocked down IGF2BP2 or METTL3 in Caki-1 and Umrc6 cells and found that the level of DUXAP9 was initially decreased (Figures 5E, F).